IN human orthotopic liver transplantation (LTX) intraoperative elevations of TNF-t (> 100 pg]ml) and (>800 pg/ml) have been found to correlate with early post-operative rejections and infections respectively. In this study the possible mechanism responsible for the induction of these cytokines has been investigated during liver allografting in 38 recipients. Intraoperative elevations of TNF-t (> 100 pg/ml) were detected in the majority of pre-transplant endotoxin positive recipients (8/12, > 10 endotoxin units/ml), the patients turning endotoxin positive until the end of grafting (3/5), and in a subgroup (6/21 patients), apparently endotoxin negative for the whole operation. Therefore endotoxin (ET) seems to stimulate release of TNF-t in approximately 50% of the patients, whereas sensitized Kupffer graft cells or immediate allograft reactivity of the host are likely to account for the remaining TNF-t positive cases. Elevations of IL-6 > 800 pg/ml) were found in approximately 50% of the TNF-t positive cases, indicating partially independent regulatory pathways for IL-6 induction in the TNF-0t negative patients. In agreement with a previous study, 11/13 (85%) of the intraoperative TNF-t positive recipients rejected their grafts within the first 10 days post-operatively. These data demonstrate that ET/infection associated as well as ET independent/reperfusion associated intraoperative TNF-x elevations, promote the initiation of allograft rejection in human liver transplantation. The transient and low endotoxaemia caused by the liver grafting procedure performed without veno-venous bypass seems to be of minor importance in the intraoperative induction of TNF-t.
Introduction
Orthotopic liver transplantation is an accepted therapy for end-stage liver disease with high graft survival in properly selected patients. However, primary nonfunction of the graft, frequent rejections, post-operative multi-organ complications, infections and further complications caused by the underlying diseases are observed in the majority of the recipients. 2 With the exception of primary nonfunction, surgical problems and acute drug toxicity, the diverse biological and pathological responses in patients with post-operative complications are correlated with elevated systemic and local levels of cytokines, as TNF-, IL-1, IL-6, IL-8 and others. 3 Clinical and animal experimental liver transplantations are associated with systemic circulation of intestine derived endotoxin during recirculation after the anhepatic phase, possibly resulting in release of TNF-0 and various other kinds of cytokines and toxic mediators from Kupffer cells and alveolar macrophages. 4 High peripheral blood concentrations of TNF-0 were found in clinical allograft rejection, septic shock and hepatopulmonary damage in experimental animal models, Anti-TNF-0 antibodies were demonstrated to prolong graft survival, reverse rejections and to diminish the hepatic and pulmonary damage, providing clear evidence for the direct functional participation of TNF-cz in graft damage and inflammation. 5'6 In a previous study we measured the (Fig. 1) . In ET positive patients (group 1), the ET concentrations were further increased during the anhepatic phase (C-D), dropped upon recirculation (E) and returned to pre-operative positive levels at the end of the operation (F; Fig.  1 ). In patients turning ET positive, the continuous increase in ET started in the early phase (B) of liver transplantation and for the two remaining groups (3 and 4) the highest ET concentrations were found at the end of the anhepatic phase (observation D).
Intraoperative plasma concentrations of TNF-o and IL-6: For TNF-6/38 patients were positive (>100 pg/ml) pre-operatively and exhibited a doubling of their TNF-plasma concentrations during liver transplantation ( Fig. 2A, group 1 published previously, the TNF-elevation became apparent at the initiation of the recirculation ( Fig. 
2A, group 2, E).
v IL-6 was found to be elevated (> 800 pg/ml) pre-operatively in 4/38 patients (Fig.  2B, group 1 
